[en] Metalloproteinases (MMPs) are central effectors in endometrial physiology. Their production is tightly regulated by ovarian steroids and cytokines. Using zymography, we investigated MMP-2 production by human endometrial cells treated with estradiol-17beta + progesterone (E(2)+P) and by various key cytokines in endometrial physiology (IL-1beta, LIF, TGF-beta, and TNF-alpha). No gelatinase activity was detected in the culture media of epithelial cells. In basal conditions, stromal cells produced the pro form of MMP-2. MMP-2 production/activation was not directly affected by cytokine treatment. Interestingly, activated MMP-2 was only detected after treatment of stromal cells with culture medium from epithelial cells. Cytokine treatment of epithelial cells increased the capacity of conditioned medium to stimulate stromal cells to activate MMP-2. As the tissue inhibitor of MMP-2 (TIMP-2) is a regulator of gelatinase A activity, its concentration was measured by ELISA. TIMP-2 production by stromal cells was not affected by cytokines or by epithelial cell-conditioned medium. These results strongly suggest that regulation of stromal MMP-2 activation involves soluble factor(s) derived from the epithelial compartment.
Disciplines :
Life sciences: Multidisciplinary, general & others
Author, co-author :
Goffin, Frédéric ; Centre Hospitalier Universitaire de Liège - CHU > > Service de gynécologie-obstétrique (CHR)
Frankenne, Francis ; Université de Liège - ULiège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement
Beliard, Aude ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie - Obstétrique
Perrier d'Hauterive, Sophie ; Centre Hospitalier Universitaire de Liège - CHU > > Service de gynécologie-obstétrique (CHR)
Pignon, M-R; Department of Tumor and Developmental Biology, Center of Immunology, University of Liège, Belgium
Geenen, Vincent ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'endocrinologie clinique
Foidart, Jean-Michel ; Université de Liège - ULiège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement
Language :
English
Title :
Human endometrial epithelial cells modulate the activation of gelatinase a by stromal cells.
Noyes R.W., Hertig A.T., Rock J. (1975) Dating the endometrial biopsy. Am J Obstet Gynecol 122:262-263.
Aplin J.D., Charlton A.K., Ayad S. (1988) An immunohistochemical study of human endometrial ex-tracellular matrix duing the menstrual cycle and first trimester of pregnancy. Cell Tissue Res 253:231-240.
Nagase H., Barrett A.J., Woessner J.F. Jr. (1992) Nomenclature and glossary of the matrix metalloproteinases. Matrix Suppl 1:421-424.
Nagase H. (1997) Activation mechanisms of matrix metalloproteinases. Biol Chem 378:151-160.
Murphy G., Stanton H., Cowell S. (1999) Mechanisms for pro matrix metalloproteinase activation. APMIS 107:38-44.
Gomez D.E., Alonso D.F., Yoshiji H., Thorgeirsson U.P. (1997) Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions. Eur J Cell Biol 74:111-122.
Rodgers W.H., Matrisian L.M., Giudice L.C. (1994) Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest 94:946-953.
Hulboy D.L., Rudolph L.A., Matrisian L.M. (1997) Matrix metalloproteinases as mediators of reproductive function. Mol Hum Reprod 3:27-45.
Singer C.F., Marbaix E., Lemoine P., Courtoy P.J., Eeckhout Y. (1999) Local cytokines induce differential expression of matrix metalloproteinases but not their tissue inhibitors in human endo-metrial fibroblasts. Eur J Biochem 259:40-45.
Lockwood C.J., Krikun G., Hausknecht V.A., Papp C., Schatz F. (1998) Matrix metalloproteinase and matrix metalloproteinase inhibitor expression in endometrial stromal cells during proges-tin-initiated decidualization and menstruation-related progestin withdrawal. Endocrinology 139:4607-4613.
Salamonsen L.A., Butt A.R., Hammond F.R., Garcia S., Zhang J. (1997) Production of endometrial matrix metalloproteinases, but not their tissue inhibitors, is modulated by progesterone withdrawal in an in vitro model for menstruation. J Clin Endocrinol Metab 82:1409-1415.
Osteen K.G., Keller N.R., Feltus F.A., Melner M.H. (1999) Paracrine regulation of matrix metalloproteinase expression in the normal human endometrium. Gynecol Obstet Invest 48(SUPPL. 1):2-13.
Rawdanowicz T.J., Hampton A.L., Nagase H., Woolley D.E., Salamonsen L.A. (1994) Matrix metalloproteinase production by cultured human endometrial stromal cells: Identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha. J Clin Endocrinol Metab 79:530-536.
Bruner K.L., Rodgers W.H., Gold L.I. (1995) Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl Acad Sci USA 92:7362-7366.
Huang H.Y., Wen Y., Irwin J.C., Kruessel J.S., Soong Y.K., Polan M.L. (1998) Cytokine-mediated regulation of 92-kilodalton type IV collagenase, tissue inhibitor or metalloproteinase-1 (TIMP-1), and TIMP-3 messenger ribonucleic acid expression in human endometrial stromal cells. J Clin Endocrinol Metab 83:1721-1729.
Bischof P., Martelli M., Campana A., Itoh Y., Ogata Y., Nagase H. (1995) Importance of matrix metalloproteinases in human trophoblast invasion. Early Pregnancy 1:263-269.
Bischof P., Haenggeli L., Campana A. (1995) Effect of leukemia inhibitory factor on human cytotrophoblast differentiation along the invasive pathway. Am J Reprod Immunol 34:225-230.
Schatz F., Krikun G., Runic R., Wang E.Y., Hausknecht V., Lockwood C.J. (1999) Implications of decidualization-associated protease expression in implantation and menstruation. Semin Reprod Endocrinol 17:3-12.
Zhang J., Hampton A.L., Nie G., Salamonsen L.A. (2000) Progesterone inhibits activation of latent matrix metalloproteinase (MMP)-2 by membrane-type 1 MMP: Enzymes coordinately expressed in human endometrium. Biol Reprod 62:85-94.
Matrisian L.M. (1994) Matrix metalloproteinase gene expression. Ann NY Acad Sci 732:42-50.
Irwin J.C., Kirk D., Gwatkin R.B., Navre M., Cannon P., Giudice L.C. (1996) Human endometrial matrix metalloproteinase-2, a putative menstrual proteinase. Hormonal regulation in cultured stromal cells and messenger RNA expression during the menstrual cycle. J Clin Invest 97:438-447.
Stetler-Stevenson W.G. (1994) Progelatinase A activation during tumor cell invasion. Invasion Metastasis 14:259-268.
Deryugina E.I., Luo G.X., Reisfeld R.A., Bourdon M.A., Strongin A. (1997) Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2. Anticancer Res 17:3201-3210.
Strongin A.Y., Collier I., Bannikov G., Marmer B.L., Grant G.A., Goldberg G.I. (1995) Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270:5331-5338.
Schatz F., Papp C., Toth-Pal E. (1994) Protease and protease inhibitor expression during in vitro decidualization of human endometrial stromal cells. Ann NY Acad Sci 734:33-42.
Wenzl R.J., Heinzl H. (1998) Localization of matrix metalloproteinase-2 in uterine endometrium and ectopic implants. Gynecol Obstet Invest 45:253-257.
Polette M., Nawrocki B., Pintiaux A. (1994) Expression of gelatinases A and B and their tissue inhibitors by cells of early and term human placenta and gestational endometrium. Lab Invest 71:838-846.
Bjorn S.F., Hastrup N., Lund L.R., Dano K., Larsen J.F., Pyke C. (1997) Coordinated expression of MMP-2 and its putative activator, MT1-MMP, in human placentation. Mol Hum Reprod 3:713-723.
Tseng L., Zhu H.H. (1998) Progestin, estrogen, and insulin-like growth factor-I stimulate the prolactin receptor mRNA in human endometrial stromal cells. J Soc Gynecol Invest 5:149-155.
Martelli M., Campana A., Bischof P. (1993) Secretion of matrix metalloproteinases by human endometrial cells in vitro. J Reprod Fertil 98:67-76.
Laird S.M., Li T.C., Bolton A.E. (1993) The production of placental protein 14 and interleukin 6 by human endometrial cells in culture. Hum Reprod 8:793-798.
Remacle A.G., Baramova E.N., Weidle U.H., Krell H.W., Foidart J.M. (1995) Purification of progelatinases A and B by continuouselution electrophoresis. Protein Expr Purif 6:417-422.
Remacle A., McCarthy K., Noel A. (2000) High levels of TIMP-2 correlate with adverse prognosis in breast cancer. Int J Cancer 89:118-121.
Singer C.F., Marbaix E., Lemoine P., Eeckhout Y., Courtoy P.J. (1999) Interleukin-1 receptor-ligand interactions modulate interstitial collagenase-1 production by human endometrial fibroblasts. Mol Hum Reprod 5:240-245.
Ellenrieder V., Alber B., Lacher U. (2000) Role of MT-MMPs and MMP-2 in pancreatic cancer progression. Int J Cancer 85:14-20.
Soini Y., Alarakkola E., Autio-Harmainen H. (1997) Expression of messenger RNAs for metalloproteinases 2 and 9, type IV collagen, and laminin in nonneoplastic and neoplastic endometrium. Hum Pathol 28:220-226.
Salamonsen L.A. (1994) Matrix metalloproteinases and endometrial remodelling. Cell Biol Int 18:1139-1144.
Salamonsen L.A., Woolley D.E. (1996) Matrix metalloproteinases in normal menstruation. Hum Re-prod 11(SUPPL. 2):124-133.
Nagase H., Suzuki K., Itoh Y. (1996) Involvement of tissue inhibitors of metalloproteinases (TIMPS) during matrix metalloproteinase activation. Adv Exp Med Biol 389:23-31.
Seiki M. (1999) Membrane-type matrix metalloproteinases. APMIS 107:137-143.
Ornstein D.L., MacNab J., Cohn K.H. (1999) Evidence for tumor-host cooperation in regulating MMP-2 expression in human colon cancer. Clin Exp Metastasis 17:205-212.
Polette M., Gilles C., Marchand V., Seiki M., Tournier J.M., Birembaut P. (1997) Induction of membrane-type matrix metalloproteinase 1 (MT1-MMP) expression in human fibroblasts by breast adenocarcinoma cells. Clin Exp Metastasis 15:157-163.
Corcoran M.L., Hewitt R.E., Kleiner D.E. Jr., Stetler-Stevenson W.G. (1996) MMP-2: Expression, activation and inhibition. Enzyme Protein 49:7-19.
